Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00323206
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2006-05-05
Brief Title:
Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Study Overview
Official Title:
Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research study is to study a type of gene therapy treatment called plasmid electroporation This type of treatment involves the injection of a gene into some melanoma tumors located near the surface of the skin followed by a burst of electricity into the tumor to cause the tumor to take up the gene This study is a Phase I study to determine the side effects and the correct dose of this type of treatment and also its effectiveness in treating melanoma While the electroporation technique has been used in people the combination of plasmid injection and electroporation is being tried in human beings for the first time
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None